drugset / Trial / NCT01092975
Safety of Phenylephrine for Oral Mucositis Prevention
Non-randomizedSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to determine if applying the drug phenylephrine to the inside of the mouth can be done safely and is tolerable to use in cancer patients receiving radiation to the Sub-mandibular lymph nodes.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-11
- Completion
- 2011-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Phenylephrine | Small molecule | 1.25 mg | Topical |
| Subject | Phenylephrine | Small molecule | 2.5 mg | Topical |
| Subject | Phenylephrine | Small molecule | 5 mg | Topical |
| Subject | Phenylephrine | Small molecule | 10 mg | Topical |
| Subject | Phenylephrine | Small molecule | 20 mg | Topical |
| Subject | Phenylephrine | Small molecule | 40 mg | Topical |
| Subject | Phenylephrine | Small molecule | 60 mg | Topical |
| Subject | Phenylephrine | Small molecule | 80 mg | Topical |